Statistics for Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer
Total visits
| views | |
|---|---|
| Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer | 0 |
Total visits per month
| views | |
|---|---|
| December 2022 | 0 |
| January 2023 | 0 |
| February 2023 | 0 |
| March 2023 | 0 |
| April 2023 | 0 |
| May 2023 | 0 |
| June 2023 | 0 |
File Visits
| views | |
|---|---|
| gynonc_a2021v161p787.pdf | 1 |